-
动态
9月12日，深圳大学附属华南医院泌尿外科学科带头人吴松教授带领团队，与德国夏洛特大学综合医院泌尿外科主任、欧洲泌尿外科领域领军人物Schlomm教授，举行了一场高水平的中德线上学术交流。会议由深圳大学附属华南医院泌尿外科主任侯腾主持，吴松教授致欢迎辞，为双方的深入对话拉开了序幕。在随后的介绍环节，涂门江博士详细汇报了深圳大学附属华南医院泌尿外科的临床与科研成果。作为一个成立仅三年的年轻科室，该团队凭借快速发展和扎实成绩，已经展现出与国际接轨的实力。Schlomm教授对这一成就表示高度赞赏，并指出双方团队在泌尿系统肿瘤、基因组学研究以及人工智能在医学中的应用等方面有着天然的契合点。作为欧洲泌尿外科的权威专家，Schlomm教授以“夏洛特—深圳对话：通过科研与临床经验共享推动泌尿外科发展”为主题，带来了系统而深刻的分享。在临床方面，他重点介绍了自己团队首创的全功能尿道括约肌保留前列腺癌根治术。这一术式的创新突破了传统手术的局限，在保证肿瘤治疗效果的同时，大幅提升了患者术后的尿控功能和生活质量，被誉为改善患者生存质量的重要里程碑。在科研层面，Schlomm教授展示了他们如何利用人工智能与基因数据相结合，推动精准医疗的发展。通过对大规模真实世界数据与分子层面数据的整合分析，他们能够开发出动态预测算法，不仅帮助医生更好地为患者制定个性化治疗方案，也为理解疾病发展和耐药机制提供了新思路。这些探索正在逐渐改变泌尿外科的诊疗模式，让医学从“经验驱动”走向“数据驱动”。会议气氛热烈而真诚，双方在分享经验与交流思路中找到了诸多共鸣。未来，中德双方将继续携手合作，不仅在临床诊疗技术上互学互鉴，更在科研创新上深度融合，共同探索泌尿外科的前沿方向。这场跨越国界的对话，不仅是一场学术盛宴，更是合作新征程的起点。
On September 12th, Prof. WU Song, the academic leader of the Department of Urology at South China Hospital of Shenzhen University, together with his team, had a high-level Sino-German online academic exchange with Prof. Schlomm, Director of the Department of Urology at the Charité - Universitätsmedizin Berlin in Germany. The meeting was hosted by HOU Teng, Director of the Department of Urology at South China Hospital of Shenzhen University. Prof. WU Song delivered a welcome speech for the meeting, setting the stage for in-depth dialogue between the two parties. In the subsequent introduction session, Dr. TU Menjiang gave a detailed report on the clinical and research achievements of the Department of Urology at South China Hospital of Shenzhen University. As a young department established only three years ago, the team has demonstrated internationally advanced capabilities through its rapid development and solid accomplishments. Prof. Schlomm expressed high appreciation for these achievements and pointed out that the teams of both parties have natural match in areas such as urological oncology, genomics research, and the application of artificial intelligence in medicine. As a key figure in urology in Europe, Prof. Schlomm delivered a systematic and insightful presentation entitled "Charité-Shenzhen Dialogue: Advancing Urology through Sharing Research and Clinical Experience". In terms of clinical practice, he focused on introducing his team's technique of Full Functional-Length Urethral Sphincter Preservation During Radical Prostatectomy. This innovative surgical method breaks through the limitations of conventional operations, significantly improving patients' postoperative urinary control and quality of life while ensuring effective tumor treatment, and is hailed as an important milestone in enhancing patients' quality of life. Scientifically, Prof. Schlomm demonstrated how they are promoting the development of precision medicine by combining artificial intelligence with genetic data. Through integrated analysis of large-scale real-world data and molecular-level data, they have been able to develop dynamic prediction algorithms that not only help doctors better formulate personalized treatment plans for patients but also provide new insights into understanding disease progression and drug resistance mechanisms. These explorations are gradually changing the diagnosis and treatment model in urology, transforming medicine from "experience-driven" to "data-driven". The meeting was characterized by a warm and sincere atmosphere, with both parties finding much common ground in sharing experiences and exchanging ideas. In the future, the Chinese and German teams both will continue their cooperation, not only learning from each other in clinical diagnosis and treatment but also deeply integrating in scientific research innovation to jointly explore cutting-edge directions in urology. This cross-border dialogue is not only an academic feast but also the starting point of a new journey of cooperation.
